MORRISTOWN, N.J., Jan 06, 2010 /PRNewswire via COMTEX/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the 28th Annual JPMorgan Healthcare Conference on Wednesday, January 13, 2010 at 12:00 pm Eastern Standard Time, at the Westin St. Francis, San Francisco, CA.
This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com.
The webcast can also be accessed at the following URL:
An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.
For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.
SOURCE Watson Pharmaceuticals, Inc.